title: Corticosterone synthesis inhibitor metyrapone preserves changes in maternal behavior and neuroendocrine responses during immunological challenge in lactating rats.
abstract: Lactation is associated with profound behavioral and physiological adaptations in the mother that support reproductive success. These include neuroendocrine adaptation to stress that reduces anxiety-related behavior and emotional responsiveness. However, the way in which endogenous glucocorticoids secreted during immunological challenge influence the neuroendocrine system and behavior of lactating rats is not well understood. To evaluate the effects of glucocorticoids on the neuroendocrine response to suckling, maternal behavior and maternal anxiolysis, lactating female rats were treated with vehicle or metyrapone prior to the administration of a saline solution or a lipopolysaccharide (LPS) solution. LPS treatment reduced oxytocin and prolactin secretion during suckling and affected a variety of maternal behaviors, such as increasing the latency of retrieval a new nest, decreasing the number of pups gathered to the nest, increasing the latency of retrieving the first pup and decreasing the percentage of time spent in the arched-nursing position. In addition, the LPS treatment increased the baseline and avoidance latencies in an elevated T-maze. Pretreatment with metyrapone counteracted effects produced by LPS, including hormonal and behavioral responses in lactating rats. Taken together, our results indicate that stress induced by LPS treatment attenuates the neuroendocrine response to suckling, followed by disruption of maternal behavior and maternal anxiolysis in lactating female rats. These changes may be due to corticosterone release, as evidenced by the reversal of behavioral and neuroendocrine responses after immunological challenge in lactating rats that had been pretreated with metyrapone.
authors.affiliation: Department of Physiological Science, Federal University of Alfenas (UNIFAL), Alfenas, Brazil. facvilela @ gmail.com
authors.forename: Fabiana C
authors.initials: FC
authors.lastname: Vilela
authors.forename: José
authors.initials: J
authors.lastname: Antunes-Rodrigues
authors.forename: Lucila L K
authors.initials: LL
authors.lastname: Elias
authors.forename: Alexandre
authors.initials: A
authors.lastname: Giusti-Paiva
mesh_terms: D000818:Animals; D003345:Corticosterone / Q000037:antagonists & inhibitors* / Q000096:biosynthesis; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D007113:Immunity, Innate / Q000187:drug effects*; D007158:Immunologic Techniques; D007774:Lactation / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D008425:Maternal Behavior / Q000187:drug effects*; D008797:Metyrapone / Q000494:pharmacology*; D009490:Neurosecretory Systems / Q000187:drug effects* / Q000502:physiology; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar
chemical_list: D004791:Enzyme Inhibitors; D003345:Corticosterone; D008797:Metyrapone